419 related articles for article (PubMed ID: 26600217)
1. Immunopathogenesis of Hepatitis C Virus Infection.
Kaplan DE
Gastroenterol Clin North Am; 2015 Dec; 44(4):735-60. PubMed ID: 26600217
[TBL] [Abstract][Full Text] [Related]
2. Current progress in host innate and adaptive immunity against hepatitis C virus infection.
Shi J; Li Y; Chang W; Zhang X; Wang FS
Hepatol Int; 2017 Jul; 11(4):374-383. PubMed ID: 28643186
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus (HCV) employs multiple strategies to subvert the host innate antiviral response.
Bode JG; Brenndörfer ED; Häussinger D
Biol Chem; 2008 Oct; 389(10):1283-98. PubMed ID: 18713016
[TBL] [Abstract][Full Text] [Related]
4. A study of innate and adaptive immune responses in beta-thalassemic patients with chronic hepatitis C virus infection.
Al-Ofairi BA; Barakat AB; Ghanim Hel-D; Shehata IH; El-Sayed MH
Egypt J Immunol; 2011; 18(1):61-76. PubMed ID: 23082481
[TBL] [Abstract][Full Text] [Related]
5. HCV immunopathogenesis: virus-induced strategies against host immunity.
Szabo G; Dolganiuc A
Clin Liver Dis; 2006 Nov; 10(4):753-71. PubMed ID: 17164116
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus and antiviral innate immunity: who wins at tug-of-war?
Yang DR; Zhu HZ
World J Gastroenterol; 2015 Apr; 21(13):3786-800. PubMed ID: 25852264
[TBL] [Abstract][Full Text] [Related]
7. Immunology of hepatitis C virus infections.
Spaan M; Janssen HL; Boonstra A
Best Pract Res Clin Gastroenterol; 2012 Aug; 26(4):391-400. PubMed ID: 23199499
[TBL] [Abstract][Full Text] [Related]
8. Natural killer cells in hepatitis C: Current progress.
Yoon JC; Yang CM; Song Y; Lee JM
World J Gastroenterol; 2016 Jan; 22(4):1449-60. PubMed ID: 26819513
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-27R Signaling Mediates Early Viral Containment and Impacts Innate and Adaptive Immunity after Chronic Lymphocytic Choriomeningitis Virus Infection.
Harker JA; Wong KA; Dallari S; Bao P; Dolgoter A; Jo Y; Wehrens EJ; Macal M; Zuniga EI
J Virol; 2018 Jun; 92(12):. PubMed ID: 29593047
[TBL] [Abstract][Full Text] [Related]
10. Immunity against hepatitis E virus infection: Implications for therapy and vaccine development.
Hakim MS; Ikram A; Zhou J; Wang W; Peppelenbosch MP; Pan Q
Rev Med Virol; 2018 Mar; 28(2):. PubMed ID: 29272060
[TBL] [Abstract][Full Text] [Related]
11. T-cell therapy for chronic viral hepatitis.
Bertoletti A; Tan AT; Koh S
Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469
[TBL] [Abstract][Full Text] [Related]
12. Immunopathogenesis of hepatitis C virus infection.
Freeman AJ; Marinos G; Ffrench RA; Lloyd AR
Immunol Cell Biol; 2001 Dec; 79(6):515-36. PubMed ID: 11903612
[TBL] [Abstract][Full Text] [Related]
13. Cell-mediated immunity and the outcome of hepatitis C virus infection.
Shoukry NH; Cawthon AG; Walker CM
Annu Rev Microbiol; 2004; 58():391-424. PubMed ID: 15487943
[TBL] [Abstract][Full Text] [Related]
14. The potential use of Toll-like receptor agonists to restore the dysfunctional immunity induced by hepatitis C virus.
Salem ML; El-Demellawy M; El-Azm AR
Cell Immunol; 2010; 262(2):96-104. PubMed ID: 20338549
[TBL] [Abstract][Full Text] [Related]
15. Organ system view of the hepatic innate immunity in HCV infection.
Bang BR; Elmasry S; Saito T
J Med Virol; 2016 Dec; 88(12):2025-2037. PubMed ID: 27153233
[TBL] [Abstract][Full Text] [Related]
16. Acute Liver Damage Associated with Innate Immune Activation in a Small Nonhuman Primate Model of Hepacivirus Infection.
Manickam C; Rajakumar P; Wachtman L; Kramer JA; Martinot AJ; Varner V; Giavedoni LD; Reeves RK
J Virol; 2016 Oct; 90(20):9153-62. PubMed ID: 27489267
[TBL] [Abstract][Full Text] [Related]
17. Truncated CXCL10 is associated with failure to achieve spontaneous clearance of acute hepatitis C infection.
Riva A; Laird M; Casrouge A; Ambrozaitis A; Williams R; Naoumov NV; Albert ML; Chokshi S
Hepatology; 2014 Aug; 60(2):487-96. PubMed ID: 24668726
[TBL] [Abstract][Full Text] [Related]
18. [Hepatitis C virus subverts pattern recognition receptors-mediated control of adaptative immunity orchestrated by dendritic cells].
Rodrigue-Gervais IG; Lamarre D
Med Sci (Paris); 2010 Oct; 26(10):869-74. PubMed ID: 20929679
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptors in hepatitis C infection: implications for pathogenesis and treatment.
Howell J; Angus P; Gow P; Visvanathan K
J Gastroenterol Hepatol; 2013 May; 28(5):766-76. PubMed ID: 23432473
[TBL] [Abstract][Full Text] [Related]
20. Pathogen-Associated Molecular Pattern Recognition of Hepatitis C Virus Transmitted/Founder Variants by RIG-I Is Dependent on U-Core Length.
Kell A; Stoddard M; Li H; Marcotrigiano J; Shaw GM; Gale M
J Virol; 2015 Nov; 89(21):11056-68. PubMed ID: 26311867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
